New Treatment Therapy Helps Inhibit Hepatitis C
Thursday, July 31, 2008 - 20:28
in Health & Medicine
Two new studies examine the use of the nucleoside polymerase inhibitor, R1626, to the standard therapy for hepatitis C.
Two new studies examine the use of the nucleoside polymerase inhibitor, R1626, to the standard therapy for hepatitis C.